logo

Bayer Ag (BYR.L)



Trade BYR.L now with
  Date
  Headline
3/12/2021 6:00:56 AM Bayer Plans To Further Strengthen Supervisory Board; Supervisory Board Compensation To Be Adjusted
3/10/2021 7:56:24 AM Bayer Expects Core EPS To Be EUR 7.00-EUR 7.50 In 2024 Based On Constant Currencies
2/25/2021 1:32:19 AM Bayer Q4 EPS EUR 0.32 Vs EUR 1.44 Last Year
2/22/2021 1:32:00 AM New Drugs Approved In January
2/8/2021 7:09:34 AM Bayer, Orion Expand Clinical Development Program For Oral ARi NUBEQA In Prostate Cancer
2/3/2021 5:15:16 PM Bayer Announces Formal Agreement With Plaintiffs' Class Counsel On Class Plan
2/3/2021 6:34:11 AM Bayer Receives Approval For Nubeqa In China For Treatment Of Men With NmCRPC
2/1/2021 2:11:24 AM Bayer Receives Approval For Use Of Its Oral Factor Xa Inhibitor Xarelto
1/13/2021 3:16:00 AM Bayer Presents Progress In Transforming Its Pharmaceutical Business
12/21/2020 7:54:22 AM WuXi Biologics To Take Over And Operate Drug Substance Facility At Bayer's Wuppertal Site
12/1/2020 3:12:07 AM Bayer Announces Placement Of Elanco Shares For Gross Proceeds Of $1.6 Bln At Completion